Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases

  • Read more about Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases
US Application 09/856,544
Filed on 2001-12-20

Inhibitors of Formation of Protease Resistant Prion Protein

  • Read more about Inhibitors of Formation of Protease Resistant Prion Protein
US Patent 6,355,610
Filed on 2001-03-30

Methods For Enhancing Oral Tolerance and Treating Autoimmune Disease Using Inhibitors of Intereukin-12

  • Read more about Methods For Enhancing Oral Tolerance and Treating Autoimmune Disease Using Inhibitors of Intereukin-12
US Application 09/732,502
Filed on 2000-12-07

Production of Infectious Respiratory Syncytial Virus From Cloned Nucleotide Sequences

  • Read more about Production of Infectious Respiratory Syncytial Virus From Cloned Nucleotide Sequences
Patent Cooperation Treaty
PCT/US96/15524
Filed on 1996-09-27

Pertussin Toxin Gene: Cloning and Expression of Protective Antigen

  • Read more about Pertussin Toxin Gene: Cloning and Expression of Protective Antigen
US Application 09/770,875
Filed on 2001-01-26

Inhibitors of Amyloid Formation

  • Read more about Inhibitors of Amyloid Formation
US Patent 6,632,808
Filed on 2001-03-07

T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME

  • Read more about T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME
US Application 09/776,522
Filed on 2001-02-02

T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME

  • Read more about T CELL RECEPTOR LIGANDS AND METHODS OF USING SAME
US Application 09/776,520
Filed on 2001-02-02

Recombinant Proteins of The Pakistani Strain of Hepatitis E and Their Use In Diagnostic Methods in Vaccines

  • Read more about Recombinant Proteins of The Pakistani Strain of Hepatitis E and Their Use In Diagnostic Methods in Vaccines
US Patent 6,787,145
Filed on 2000-11-28

Full-Length Infectious cDNA Clones Of Tick Borne Flavivirus

  • Read more about Full-Length Infectious cDNA Clones Of Tick Borne Flavivirus
Patent Cooperation Treaty
PCT/US01/04460
Filed on 2001-02-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 542
  • Page 543
  • Page 544
  • Page 545
  • Page 546
  • Page 547
  • Page 548
  • Page 549
  • Page 550
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health